Interface Biosciences Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Interface Biosciences is a biotechnology research company focused on discovering microbial natural products that have low toxicity and the ability to modulate the immune system, with the aim of addressing chronic inflammatory diseases. Based in Palo Alto, California, the firm positions itself as a therapeutic platform, identifying microbial metabolites that may support immune modulation and offer potential treatment options in inflammatory contexts. The company operates within the biotechnology research sector, serving clients and collaborators interested in advancing natural product-derived therapies.* In recent developments, Interface announced a seed funding round in late 2023 to support its research and development efforts.